Showing results (181-190 of 524) with videos related to
Sort By:
Pageof 53
Circulation|July 6, 2000
Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respirationD D Sin, A G Logan, F S Fitzgerald, et al.Chest|October 4, 2016
Biomarker Development in COPD: Moving From P Values to Products to Impact Patient CareZsuzsanna Hollander, Mari L DeMarco, Mohsen Sadatsafavi, et al.Respiratory Research|May 21, 2020
Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort studyAjn Raymakers, D D Sin, M Sadatsafavi, et al.American Journal of Respiratory and Critical Care Medicine|October 6, 1999
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failureD D Sin, F Fitzgerald, J D Parker, et al.Canadian Respiratory Journal|October 25, 2008
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission ratesAlyson W M Wong, Wen Q Gan, Jane Burns, et al.Thorax|July 5, 2005
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysisS Wasswa-Kintu, W Q Gan, S F P Man, et al.Chest|February 17, 2017
The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-Based Cohort StudyAdam J N Raymakers, Mohsen Sadatsafavi, Don D Sin, et al.Plos One|March 4, 2014
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosisBradley S Quon, David A Ngan, Pearce G Wilcox, et al.Therapeutic Advances in Respiratory Disease|July 30, 2009
The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary diseaseDavid A Ngan, Shawna V Vickerman, David J Granville, et al.Plos One|April 26, 2014
Longer telomere length in COPD patients with α1-antitrypsin deficiency independent of lung functionAabida Saferali, Jee Lee, Don D Sin, et al.Pageof 53